Wilson Sonsini advised Replay on the deal. Replay, a genome writing company reprogramming biology by writing and delivering big DNA, announced its launch with $55 million...
Replay’s $55 Million Seed Funding
ReCode Therapeutics’ $120 Million Series B Financing
Wilson Sonsini Goodrich & Rosati represented ReCode Therapeutics in the transaction. ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of...